Karin Kramer Nielsen

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

K. Br�sen, J G Hansen, Karin Kramer Nielsen et al. · European Journal of Clinical Pharmacology · 1993 · 193 citations

Pharmacological Study, Biochemistry, Medicine +8

The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways.

Karin Kramer Nielsen, J P Flinois, Philippe Beaune et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 92 citations

Single-dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms

Karin Kramer Nielsen, Kim Brøsen, M. G. J. Hansen et al. · Clinical Pharmacology & Therapeutics · 1994 · 92 citations

S-mephenytoin Oxidation Polymorphisms, Mg Clomipramine Hydrochloride, Pharmacotherapy +16

Absorption, metabolism and excretion of a single oral dose of 14 C-repaglinide during repaglinide multiple dosing

P. N. M. van Heiningen, Vibeke Hatorp, Karin Kramer Nielsen et al. · European Journal of Clinical Pharmacology · 1999 · 82 citations

Therapeutic Drug Monitoring, Repaglinide Multiple Dosing, Pharmacology +6

The hypoalgesic effect of imipramine in different human experimental pain models

Lars K. Poulsen, Lars Arendt‐Nielsen, Kim Brøsen et al. · Pain · 1995 · 75 citations

Pain Tolerance Thresholds, Pain Therapy, Acute Pain +19